Palomar Holdings, Inc. Common stock

Palomar's RSI of 29.3 signals deeply oversold territory, yet the stock trades at a reasonable 15.25x earnings—hardly a screaming bargain relative to insurance peers. With market cap just shy of $3B and only 2.92% short interest, there's minimal squeeze catalyst lurking. The disconnect between technical weakness and valuation suggests either the market is pricing in structural headwinds for this specialty insurer, or the selloff has outpaced fundamental deterioration. Either way, the oversold reading creates potential mean-reversion pressure, though conviction requires clarity on whether operational challenges or sector rotation drove the decline. The modest short float provides little fuel for a violent bounce.